PATENT CLAIM ANALYSIS

Application Number: 16270808
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["424", "449000"]

Abstract:
A transdermal drug delivery composition comprises an acrylate copolymer and from about 8% to about 30% by weight fentanyl. A transdermal fentanyl delivery composition comprising methyl laurate or tetraglycol as a permeation enhancer is also provided. The transdermal drug delivery compositions can be used to make a transdermal drug delivery device for the delivery of fentanyl.

Claim (Index 7):
The patch of  claim 1  wherein the reservoir further comprises an enhancer.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 99.0
- Lexical Diversity: 1.45238
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['10744996', '10222007', '09901219', '14757954', '10835535']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7384947867293875
- 35 USC 102 Novelty (BERT): 0.5170836559556831
- Combined Prediction Score: 0.7163536736520171
- Mean Citation Score: 214.854134
- Max Citation Score: 217.74004
- Similarity Product: 111.3752506295204

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test